Lincoln Pharmaceuticals Ltd (LINCOLN) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 294056, "name": "Lincoln Pharma.", "stock_name": "Lincoln Pharma.", "full_name": "Lincoln Pharmaceuticals Ltd", "name_url": "stocks-analysis/lincoln-pharma", "exchange": 1, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "679.15", "chg": -20.45, "chgp": "-2.92%", "dir": -1, "prev_price": "699.60", "mcapval": "1,360.32 Cr", "mcap": "Micro Cap", "scripcode": 531633, "symbol": "LINCOLN", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE405C01035", "curr_date": "May 12", "curr_time": "", "bse_nse_vol": "56.2 k", "exc_status": "Active", "traded_date": "May 12, 2026", "traded_date_str": "2026 05 12", "score": "", "scoreText": "", "Live": 0, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lincoln-pharma-294056-1&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Lincoln Pharmaceuticals Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/lincoln-pharmaceuticals-ltd-is-rated-hold-3985477", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/LincolnPharmace_mojoScore_3985477.png", "date": "2026-05-11 10:10:02", "description": "Lincoln Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 Mar 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 11 May 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing." }, { "title": "Lincoln Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3974666", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/LincolnPharmace_technicaldot_3974666.png", "date": "2026-05-05 08:01:25", "description": "Lincoln Pharmaceuticals Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish trend as of early May 2026. Despite a slight dip in daily price, key technical indicators present a mixed picture, signalling both opportunities and caution for investors navigating the pharmaceuticals and biotechnology sector." }, { "title": "Lincoln Pharmaceuticals Gains 6.93%: 2 Key Factors Driving the Week’s Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-gains-693-2-key-factors-driving-the-weeks-momentum-3971891", "imagepath": "", "date": "2026-05-03 11:00:04", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>Apr 27:</strong> Valuation upgrade signals renewed price attractiveness</p>\n <p><strong>Apr 29:</strong> New 52-week high reached at Rs.710.9</p>\n <p><strong>Apr 30:</strong> Profit-taking leads to a 4.19% correction</p>\n <p><strong>May 1:</strong> No trading data available</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.603.55</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.645.40</div><div class=\"stat-change positive\">+6.93..." }, { "title": "Lincoln Pharmaceuticals Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/lincoln-pharmaceuticals-ltd-is-rated-hold-3970099", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/LincolnPharmace_mojoScore_3970099.png", "date": "2026-04-30 10:10:03", "description": "Lincoln Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 March 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 30 April 2026, providing investors with the latest insights into its performance and outlook." }, { "title": "Broad-Based Technical Strength Lifts Lincoln Pharmaceuticals Ltd to 52-Week High of Rs 710.9", "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-hits-new-52-week-high-at-rs7109-3968002", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/LincolnPharmace_priceRelatedfactors_3968002.png", "date": "2026-04-29 10:10:20", "description": "With a decisive surge to Rs 710.9 on 29 Apr 2026, Lincoln Pharmaceuticals Ltd has reached a fresh 52-week high, marking a notable milestone in its price momentum. This rally comes amid a backdrop of strong technical signals and sustained gains over the past three sessions, underscoring the stock's robust upward trajectory." }, { "title": "Lincoln Pharmaceuticals Ltd: Valuation Shifts Signal Renewed Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-valuation-shifts-signal-renewed-price-attractiveness-3963481", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/LincolnPharmace_valuationdot_3963481.png", "date": "2026-04-27 08:00:14", "description": "Lincoln Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating, signalling a potential opportunity for investors amid a mixed performance in the Pharmaceuticals & Biotechnology sector. This change is underpinned by improved price-to-earnings and price-to-book value ratios relative to its historical averages and peer group, despite a modest decline in its share price on 27 Apr 2026." }, { "title": "Lincoln Pharmaceuticals Ltd Sees Bullish Momentum Shift Amid Technical Upgrades", "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-sees-bullish-momentum-shift-amid-technical-upgrades-3954897", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/LincolnPharmace_technicaldot_3954897.png", "date": "2026-04-21 08:01:28", "description": "Lincoln Pharmaceuticals Ltd has demonstrated a notable shift in price momentum, supported by a series of bullish technical indicators across multiple timeframes. The stock’s recent upgrade from a Sell to a Hold rating reflects improving market sentiment and technical strength, positioning it favourably within the Pharmaceuticals & Biotechnology sector." }, { "title": "Lincoln Pharmaceuticals Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/lincoln-pharmaceuticals-ltd-is-rated-hold-3953036", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/LincolnPharmace_mojoScore_3953036.png", "date": "2026-04-19 10:10:03", "description": "Lincoln Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 March 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 19 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Lincoln Pharmaceuticals Gains 1.82%: 3 Key Factors Driving the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-gains-182-3-key-factors-driving-the-week-3952805", "imagepath": "", "date": "2026-04-19 10:00:04", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>13 Apr:</strong> Stock edged up slightly to Rs.576.35 despite Sensex decline</p>\n <p><strong>15 Apr:</strong> Strong rally of 2.85% to Rs.592.80 amid Sensex surge</p>\n <p><strong>16 Apr:</strong> Technical and valuation upgrades announced, stock steady at Rs.592.40</p>\n <p><strong>17 Apr:</strong> Mild pullback to Rs.586.60 amid mixed technical signals</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.576.10</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</di..." } ], "total": 973, "sid": "294056", "stock_news_url": "https://www.marketsmojo.com/news/lincoln-pharmaceuticals-294056" }, "announcements": [ { "details": "Lincoln Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on December 07, 2019 for consider and approved draft scheme of amalgamation and withdrawal scheme approved by Board earlier", "source": "NSE", "caption": "Lincoln Pharmaceuticals Limited - Outcome of Board Meeting", "datetime": "09-Dec-2019" }, { "details": "Lincoln Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on November 14, 2019 for Considered and Approved Un-Audited Standalone and Consolidated Financial Results for the Quarter and Half Year Ended on September 30, 2019", "source": "NSE", "caption": "Lincoln Pharmaceuticals Limited - Outcome of Board Meeting", "datetime": "14-Nov-2019" }, { "details": "Lincoln Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 22, 2019, titled \"press release dated October 22, 2019 titled \"Lincoln Pharmaceuticals Limited receives a Patent for Diclofenac Rectal Spray. \".", "source": "NSE", "caption": "Lincoln Pharmaceuticals Limited - Press Release", "datetime": "22-Oct-2019" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Lincoln Pharmaceuticals Ltd has declared <strong>18%</strong> dividend, ex-date: 12 Sep 25", "dt": "2025-09-12", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Lincoln Pharmaceuticals Ltd has announced <strong>10:2</strong> stock split, ex-date: 19 Mar 09", "dt": "2009-03-19", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

Apr 27: Valuation upgrade signals renewed price attractiveness

Apr 29: New 52-week high reached at Rs.710.9

Apr 30: Profit-taking leads to a 4.19% correction

May 1: No trading data available

Read full news article

Lincoln Pharmaceuticals Ltd is Rated Hold

2026-04-30 10:10:03

Lincoln Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 March 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 30 April 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Broad-Based Technical Strength Lifts Lincoln Pharmaceuticals Ltd to 52-Week High of Rs 710.9

2026-04-29 10:10:20

With a decisive surge to Rs 710.9 on 29 Apr 2026, Lincoln Pharmaceuticals Ltd has reached a fresh 52-week high, marking a notable milestone in its price momentum. This rally comes amid a backdrop of strong technical signals and sustained gains over the past three sessions, underscoring the stock's robust upward trajectory.

Read full news article

Lincoln Pharmaceuticals Ltd: Valuation Shifts Signal Renewed Price Attractiveness

2026-04-27 08:00:14

Lincoln Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating, signalling a potential opportunity for investors amid a mixed performance in the Pharmaceuticals & Biotechnology sector. This change is underpinned by improved price-to-earnings and price-to-book value ratios relative to its historical averages and peer group, despite a modest decline in its share price on 27 Apr 2026.

Read full news article

Lincoln Pharmaceuticals Ltd Sees Bullish Momentum Shift Amid Technical Upgrades

2026-04-21 08:01:28

Lincoln Pharmaceuticals Ltd has demonstrated a notable shift in price momentum, supported by a series of bullish technical indicators across multiple timeframes. The stock’s recent upgrade from a Sell to a Hold rating reflects improving market sentiment and technical strength, positioning it favourably within the Pharmaceuticals & Biotechnology sector.

Read full news article

Lincoln Pharmaceuticals Ltd is Rated Hold

2026-04-19 10:10:03

Lincoln Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 March 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 19 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.